- Company Information
- Change The World
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Updated:6/3/26
- Country/Territory:U.S.
- Headquarters:Greenfield, Ind.
- Industry:Pharmaceuticals
- CEO:Jeffrey N. Simmons
- Website:https://www.elanco.com
- Ticker:ELAN
- Company type:Public
- Revenues ($M):$4,715
- Profits ($M):$-232
- Market value ($M):$11,897
- Number of employees:9,650
Market value as of March 31, 2026.
- Impact Segment:Public Health/Nutrition
- Sector:Health Care
- $ millions% change
- Revenues ($M):$4,7156.2%
- Profits ($M):$-232-168.6%
- Assets ($M):$13,358-
- Total Stockholder Equity ($M):$6,547-
- Profit as % of Revenues:-4.9%
- Profits as % of Assets:-1.7%
- Profits as % of Stockholder Equity:-3.5%
- Earnings Per Share ($):-0.50
- EPS % Change (from prior fiscal year):-169.1%
- EPS % Change (5 year annual rate):-
- EPS % Change (10 year annual rate):-
- Total Return to Investors (last year):86.9%
- Total Return to Investors (5 year, annualized):-5.9%
- Total Return to Investors (10 year, annualized):-
Elanco Animal Health stock chart
Elanco Animal Health in Fortune Rankings
- Fortune 500
- Change the World